Company · CIK 0001231457 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
GENELUX Corp · GNLX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 SForm 4 → | Sep 2, 7:05 pm EDT | Joseph CappelloChief Technical Officer | 10,257 | $2.74 | $28,112 | 318,480 | −3.12% | |
| Aug 31, 2026 SForm 4 → | Sep 2, 7:05 pm EDT | Thomas ZindrickPresident and CEO | 34,463 | $2.67 | $91,899 | 1,226,427 | −2.73% | |
| Aug 31, 2026 SForm 4 → | Sep 2, 7:05 pm EDT | Yong YuChief Scientific Officer | 9,683 | $2.75 | $26,658 | 258,688 | −3.61% | |
| Aug 4, 2026 SForm 4 → | Aug 4, 8:20 pm EDT | Yong YuChief Scientific Officer | 653 | $2.94 | $1,922 | 268,371 | −0.24% | |
| Aug 4, 2026 SForm 4 → | Aug 4, 8:20 pm EDT | Joseph CappelloChief Technical Officer | 653 | $2.95 | $1,924 | 328,737 | −0.20% | |
| Aug 4, 2026 SForm 4 → | Aug 4, 8:20 pm EDT | Thomas ZindrickPresident and CEO | 3,023 | $2.95 | $8,905 | 1,260,890 | −0.24% | |
| Jul 1, 2026 SForm 4 → | Jul 2, 4:35 pm EDT | John W SmitherDirector | 12,000 | $2.91 | $34,898 | 91,403 | −11.6% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.